List of Elanco patents

Patents where

Current Assignee

Name

Elanco

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10420831 Inactivation of viruses by delipidation	Patent 10420831 was granted and assigned to Elanco on September, 2019 by the United States Patent and Trademark Office.	Eli Lilly	Elanco	United States Patent and Trademark Office	10420831	September 24, 2019
‌ US Patent 11638434 Feed additive compositions	Patent 11638434 was granted and assigned to Elanco on May, 2023 by the United States Patent and Trademark Office.	Elanco	Elanco	United States Patent and Trademark Office	11638434	May 2, 2023
‌ US Patent 11439703 Enhanced immune response in porcine species		Bayer	Elanco	United States Patent and Trademark Office	11439703	September 13, 2022
‌ US Patent 11273202 Formulations for bovine granulocyte colony stimulating factor and variants thereof			Elanco	United States Patent and Trademark Office	11273202	March 15, 2022
‌ US Patent 11548895 Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile		Elanco	Elanco	United States Patent and Trademark Office	11548895	January 10, 2023
‌ US Patent 11344047 Methods and formulations for reducing bovine emissions	Patent 11344047 was granted and assigned to Elanco on May, 2022 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	11344047	May 31, 2022
‌ US Patent 11439701 Bovine respiratory disease vaccine		Elanco	Elanco	United States Patent and Trademark Office	11439701	September 13, 2022
‌ US Patent 10029002 Methods and compositions for reducing the environmental impact of animal waste	Patent 10029002 was granted and assigned to Elanco on July, 2018 by the United States Patent and Trademark Office.	Elanco	Elanco	United States Patent and Trademark Office	10029002	July 24, 2018
‌ US Patent 10471133 Methods and compositions for reducing the environmental impact of animal waste	Patent 10471133 was granted and assigned to Elanco on November, 2019 by the United States Patent and Trademark Office.	Elanco	Elanco	United States Patent and Trademark Office	10471133	November 12, 2019
‌ US Patent 10370375 Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors	Patent 10370375 was granted and assigned to Elanco on August, 2019 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10370375	August 6, 2019
‌ US Patent 10000811 Markers to predict macrocyclic lactone drug resistance in dirofilaria immitis, the causative agent of heartworm disease	Patent 10000811 was granted and assigned to Elanco on June, 2018 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10000811	June 19, 2018
‌ US Patent 10117849 Monensin water dispersible granules by wet granulation	Patent 10117849 was granted and assigned to Elanco on November, 2018 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10117849	November 6, 2018
‌ US Patent 10981897 Heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds for controlling ectoparasites	Patent 10981897 was granted and assigned to Elanco on April, 2021 by the United States Patent and Trademark Office.	Elanco	Elanco	United States Patent and Trademark Office	10981897	April 20, 2021
‌ US Patent 9987267 Transdermal formulations of pergolide and uses thereof	Patent 9987267 was granted and assigned to Elanco on June, 2018 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	9987267	June 5, 2018
‌ US Patent 11414703 Markers to predict macrocyclic lactone drug resistance in			Elanco	United States Patent and Trademark Office	11414703	August 16, 2022
‌ US Patent 10941206 Chimeric canine anti-CD20 antibody	Patent 10941206 was granted and assigned to Elanco on March, 2021 by the United States Patent and Trademark Office.	Elanco	Elanco	United States Patent and Trademark Office	10941206	March 9, 2021
‌ US Patent 10300126 Porcine reproductive and respiratory syndrome vaccine virus	Patent 10300126 was granted and assigned to Elanco on May, 2019 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10300126	May 28, 2019
‌ US Patent 10828362 Preparation of live vaccines	Patent 10828362 was granted and assigned to Elanco on November, 2020 by the United States Patent and Trademark Office.	Elanco	Elanco	United States Patent and Trademark Office	10828362	November 10, 2020
‌ US Patent 9913824 Methods for internally controlling or treating equine bot larvae	Patent 9913824 was granted and assigned to Elanco on March, 2018 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	9913824	March 13, 2018
‌ US Patent 10155035 Porcine reproductive and respiratory syndrome vaccine virus	Patent 10155035 was granted and assigned to Elanco on December, 2018 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10155035	December 18, 2018
‌ US Patent 10261092 Cross-reactive determinants and methods for their identification	Patent 10261092 was granted and assigned to Elanco on April, 2019 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10261092	April 16, 2019
‌ US Patent 10874618 Compositions for treatment of heart failure in dogs			Elanco	United States Patent and Trademark Office	10874618	December 29, 2020
‌ US Patent 10519244 Chimeric canine anti-CD20 antibody	Patent 10519244 was granted and assigned to Elanco on December, 2019 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10519244	December 31, 2019
‌ US Patent 10711066 Anti-canine platelet derived growth factor receptor alpha antibody			Elanco	United States Patent and Trademark Office	10711066	July 14, 2020
‌ US Patent 10464889 Sulfonylaminobenzamide compounds as anthelmintics	Patent 10464889 was granted and assigned to Elanco on November, 2019 by the United States Patent and Trademark Office.		Elanco	United States Patent and Trademark Office	10464889	November 5, 2019

Results per page:

27 results

0 selected

27 results

0 selected